Capnography

Non-dispersive Infrared (NDIR) Market worth $965 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 2, 2024
Carbon, Condensate, Gas, Temperature, Health, PLC, Transport, Isoflurane, HVAC, Sevoflurane, Lidar, Oxygen, Honeywell, OTDR, Capnography, SCADA, Row, Anesthesia, Controller, Security alarm, Desflurane, Air pollution, Region, Oil, Thermography, Environmental monitoring, Textile, COVID-19, MSA, Digital, VOC, Yokogawa Electric, Amphenol, Carbon dioxide, Brownfield land, Nitrous oxide, Natural gas, Carbon monoxide, Mining, Acoustic, Environment, Optical fiber, Volatile organic compound, Plastic, Atmosphere, Water, Power, Hardware

Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.

Key Points: 
  • Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.
  • Monitoring of refrigerant gases, capnography etc are likely to boost NDIR market.
  • NDIR market for VOCs to hold high market share during the forecast period.
  • Industrial & Manufacturing segment by vertical in NDIR industry to hold high market share during the forecast period.

Non-dispersive Infrared (NDIR) Market worth $965 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 2, 2024
Carbon, Condensate, Gas, Temperature, Health, PLC, Transport, Isoflurane, HVAC, Sevoflurane, Lidar, Oxygen, Honeywell, OTDR, Capnography, SCADA, Row, Anesthesia, Controller, Security alarm, Desflurane, Air pollution, Region, Oil, Thermography, Environmental monitoring, Textile, COVID-19, MSA, Digital, VOC, Yokogawa Electric, Amphenol, Carbon dioxide, Brownfield land, Nitrous oxide, Natural gas, Carbon monoxide, Mining, Acoustic, Environment, Optical fiber, Volatile organic compound, Plastic, Atmosphere, Water, Power, Hardware

Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.

Key Points: 
  • Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.
  • Monitoring of refrigerant gases, capnography etc are likely to boost NDIR market.
  • NDIR market for VOCs to hold high market share during the forecast period.
  • Industrial & Manufacturing segment by vertical in NDIR industry to hold high market share during the forecast period.

Thought Tech Celebrates 50 Years in Business Providing Technology for Better Health

Retrieved on: 
Monday, February 5, 2024
Certification, Tech, Research, Gold standard, ISO, Athlete, GSR, Mental health, Education, Medical device, CE, Physiology, Health, Neuro, VR, Conference, Capnography, Hospital

MONTREAL, Feb. 5, 2024 /PRNewswire-PRWeb/ -- Thought Tech is a Montreal based company that specializes in manufacturing biofeedback, neurofeedback, and psychophysiological instruments providing "Technology for Better Health." The company was founded Dec, 1974 with the introduction of the GSR 2™ - a hand-held, portable device that uses skin conductance as a measure of an individual's stress level. The device helps people achieve self-regulation using Biofeedback, as a means of keeping stress levels under control. There are more than 450,000 units used worldwide by consumers, athletes, and in thousands of hospitals for numerous health and stress management programs.

Key Points: 
  • Montreal-based Thought Tech is proud to announce its upcoming 50th anniversary providing psychophysiological instrumentation to an international customer base.
  • MONTREAL, Feb. 5, 2024 /PRNewswire-PRWeb/ -- Thought Tech is a Montreal based company that specializes in manufacturing biofeedback, neurofeedback, and psychophysiological instruments providing "Technology for Better Health."
  • Asked about reaching this milestone, Thought Tech founder Dr. Hal Myers commented, "It's hard to believe we've been at this for five decades.
  • Thought Tech sponsors a number of workshops, taught by world authorities in their fields, to teach clinical skills and the effective use of biofeedback instrumentation.

Leading Biofeedback Instrument Company, Thought Technology Ltd., Enters Co-Marketing Agreement with Better Physiology

Retrieved on: 
Wednesday, January 3, 2024
Respiration, Partnership, Mechanics, European, Habit, EEG, Heart rate, Software, Marketing, GO, Health, Emotion, Temperature, EMG, Physiology, Capnography

MONTREAL, Jan. 3, 2024 /PRNewswire-PRWeb/ -- Thought Technology, a global leader in psychophysiological monitoring technology, has partnered with Better Physiology, the creators of the CapnoTrainer® GO capnography device, to promote an innovative approach to improving health and performance. This approach blends biofeedback techniques with habits that align breathing mechanics with respiratory chemistry, offering users of both systems a more comprehensive approach.

Key Points: 
  • Thought Technology and Better Physiology, have joined forces to give their clients a powerhouse of performance training options based on combining biofeedback and capnometry techniques.
  • MONTREAL, Jan. 3, 2024 /PRNewswire-PRWeb/ -- Thought Technology, a global leader in psychophysiological monitoring technology, has partnered with Better Physiology , the creators of the CapnoTrainer® GO capnography device, to promote an innovative approach to improving health and performance.
  • Helen Mavros, Director of Sales and Marketing at Thought Technology, expressed enthusiasm for the partnership with Better Physiology and the added benefits capnometry offers.
  • Better Physiology founder, Peter Litchfield commented, "Better Physiology looks forward to working with the world leader in biofeedback technology, Thought Technology, a team of professionals who can bring our new CapnoTrainer technology to the biofeedback community worldwide.

Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77

Retrieved on: 
Tuesday, December 5, 2023
Capnography, Research, Safety, Anesthesia, Pediatrics, Nursing, Incidence, Chief Dental Officer (Canada), Privacy, Surgeon, Respiratory rate, NORA, Cleveland Clinic, Patient, Stethoscope, Multimedia, Airway obstruction, Algorithm, FDA, Esophagogastroduodenoscopy, Faith, Communication, Software, Speech, Patent, ASA, AI, Intubation, Colonoscopy, Apnea, Friction, Medical device, Dentistry, Anesthesiology

The company's proprietary Airmod system, an active noise-canceling electronic stethoscope that seamlessly integrates with AI, enables continuous monitoring of patients' breathing sounds.

Key Points: 
  • The company's proprietary Airmod system, an active noise-canceling electronic stethoscope that seamlessly integrates with AI, enables continuous monitoring of patients' breathing sounds.
  • In collaboration with Taiwan's major medical centers and teaching hospitals, Heroic Faith has collected over 1.6 million entries of breathing sound data for AI training.
  • Heroic Faith's new General Manager, Yuan-Ren Cheng, has recently updated the company's motto from 'Saving Lives Through Innovation' to 'Saving Lives Through Communication.'
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/saving-lives-through-communicat...
    SOURCE Heroic Faith Medical Science, Inc.

Smile Train-Lifebox tackle major gap in anesthesia safety in low-resource setting operating rooms

Retrieved on: 
Tuesday, October 17, 2023
Capnography, The Nairobi Hospital, Hospital, WHO Surgical Safety Checklist, Death, International standard, Risk, Safety, Brain damage, ORS, Smile, WHO, Patient, World Health Organization, Patient safety, Cleft, Checklist, Society, Pulse, Child, Smile Train, Research, Operating, Dentistry, Lifebox, Anesthesia

NAIROBI, Kenya and NEW YORK, Oct. 16, 2023 /PRNewswire/ -- Ahead of World Anesthesia Day, the world's largest cleft organization, Smile Train, and safer surgery nonprofit, Lifebox, come together to highlight and address a 30-year access gap that puts the lives of people undergoing surgery in low-resource settings at significant risk.

Key Points: 
  • Yet, capnography remains largely unavailable across most low-resource setting operating rooms with research showing there is often a 100% gap between the need for capnography and its availability in low-income countries.
  • Increasing available capnography will significantly bridge the gap in anesthesia safety for people—including children—undergoing surgery in low-resource settings.
  • This work is part of the Smile Train-Lifebox Safe Surgery and Anesthesia Initiative to strengthen the safety of pediatric anesthesia and surgical care in low-and middle-income countries.
  • Furthermore, the WHO's Surgical Safety Checklist must include a capnograph—in addition to a pulse oximeter—as anesthesia monitoring equipment required for safe surgery.

Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders

Retrieved on: 
Friday, May 26, 2023
Hospitals, Health Technology, Health, Medical Devices, Stork, Failure, Marketing, Independent Board for Presbyterian Foreign Missions, Hospital, Acquisition, NTM, Patient, Risk, Align, Nasdaq Composite, Stock dilution, Research, Organization, Android (operating system), Apple, Growth, Behavior, Exercise, Pressure, Employment, History, SET, Capnography, Traction, Letter, Intuitive Surgical, Lead, Sound, Pyronia, OUS, Cryptocurrency, Renewable energy, Medical device, Fine chemical, Risk management, Pharmaceutical industry, Security (finance), Management, Medical imaging, COVID-19, Masimo, ResMed, Adjustment, Nicholas H. Politan, DEI Holdings

Rainbow®, Hospital AutomationTM, Radius PPG®, and other advanced technologies have given hospitals further reasons to standardize on Masimo SET®.

Key Points: 
  • Rainbow®, Hospital AutomationTM, Radius PPG®, and other advanced technologies have given hospitals further reasons to standardize on Masimo SET®.
  • Masimo has traditionally had seven directors, but due to retirements and Covid, the Board now has five.
  • Electing Quentin Koffey to the Board threatens Masimo’s mission, principles, strategy and leadership and jeopardizes the potential of your investment in Masimo.
  • Any vote on the blue proxy card will revoke your prior vote on a WHITE proxy card, and only your latest-dated proxy counts.

ESO Releases 2023 ESO EMS Index to Explore Key Trends and Measures Affecting EMS Agencies across the Country

Retrieved on: 
Tuesday, April 11, 2023
Technology, Hospitals, Health Technology, Cardiology, Software, Other Health, General Health, Pharmaceutical, Health, Data Management, Naloxone, ESO, EKG, Respiratory rate, Stroke, NSTEMI, Record, STEMI, Research, Attention, EMS, JPMorgan GBI-EM Index, Capnography, Hospital, Oxygen saturation (medicine), Patient, Emergency medical services, Ketamine, Drug, Periodic breathing, CPR, Public health surveillance, Nursing, Medical device

ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state and federal agencies, today announced the findings of its 2023 ESO EMS Index .

Key Points: 
  • ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state and federal agencies, today announced the findings of its 2023 ESO EMS Index .
  • Additionally, this year’s Index takes a deeper look at patient race/ethnicity and gender across metrics to identify inequities in care.
  • “Ketamine use in EMS has been a topic of interest in recent years due to patient safety concerns.
  • Additionally, as the Index findings indicates, there is opportunity for improvement in monitoring a patient’s EtCO2 following administration of ketamine.”
    The full 2023 ESO EMS Index can be downloaded here.

Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery

Retrieved on: 
Monday, January 23, 2023
Health Technology, Health, Surgery, Clinical Trials, Capnography, Mercury (element), Intensive care medicine, PACU, Brain, Journal, OLV, T2, Tanta University, King Fahd Medical City, VATS, HR, Patient, Hospital, MMSE, Temperature, EEG, Oxygen saturation (medicine), Risk, Psi, Heart rate, BP, NIRS, NIBP, Multimedia, MASI, Thermoregulation, Hypoxemia, Medical imaging, Aldrete, Group II intron

The technologies involved included O3® regional oximetry, capnography with NomoLine® sampling lines, SedLine® brain function monitoring, and multiple rainbow® Pulse CO-Oximetry measurements.

Key Points: 
  • The technologies involved included O3® regional oximetry, capnography with NomoLine® sampling lines, SedLine® brain function monitoring, and multiple rainbow® Pulse CO-Oximetry measurements.
  • They enrolled 70 patients, ages 18-65, undergoing elective VATS requiring OLV, between September 2021 and September 2022 at The King Fahd General Hospital, Jeddah.
  • In the left hemisphere, the difference became significant at T2, p = 0.09, and remained significant [T3-13], p
  • MMSE scores were significantly higher in Group II 3 hours after surgery (p = 0.0009), but not at 24 hours after surgery.

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2023

Retrieved on: 
Monday, February 20, 2023
Tidiane N'Diaye, Chronic obstructive pulmonary disease, Mechanical testing, Organization, II, Respiratory rate, Obstructive lung disease, ResMed, Diagnosis, Tuberculosis, Cystic fibrosis, Acquisition, Philips, Patient, Asthma, Geography, Food, Research, Health, Risk, COPD, Death, Marketing, Lung cancer, Vital signs, GE HealthCare, FDA, Medtronic, IP, Growth, Machine learning, Food and Drug Administration Amendments Act of 2007, Capnography, Prevalence, COVID-19, BD (company), Sustenance, Classification, Pharmaceutical industry, Medical device

The respiratory devices and equipment (diagnostic) market is expected to grow to $9.35 billion in 2026 at a CAGR of 7.8%.

Key Points: 
  • The respiratory devices and equipment (diagnostic) market is expected to grow to $9.35 billion in 2026 at a CAGR of 7.8%.
  • Asia Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2022.North America was the second largest region in the respiratory devices and equipment (diagnostic) market.
  • The main products of the respiratory devices and equipment (diagnostic) market are instruments and devices, assays, and reagents.The respiratory instruments and devices are used to diagnose respiratory disorders.
  • The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry.